Article
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
The oncologist - 1 Jul 2021
Massoth Lucas R, Hung Yin P, Ferry Judith A, Hasserjian Robert P, Nardi Valentina, Nielsen G Petur, Sadigh Sam, Venkataraman Vinayak, Selig Martin, Friedmann Alison M, Samore Wesley, Killian Jonathan Keith, Milante Riza, Giessinger Joseph, Foley-Peres Kathleen, Marcus Chelsea, Severson Eric, Duncan Daniel, Sivakumar Smruthy, Ross Jeffrey S, Desphande Vikram, Ramkissoon Shakti H, Vergilio Jo-Anne, Louissaint Abner, Zukerberg Lawrence R, Williams Erik A
Abstract excerpt
BACKGROUND: Histiocytic and dendritic cell neoplasms are a diverse group of tumors arising from monocytic or dendritic cell lineage. Whereas the genomic features for Langerhans cell histiocytosis and Erdheim-Chester disease have been well described, other less common and often aggressive tumors in this broad category remain poorly characterized, and comparison studies across the World Health Organization...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
